Atomo is a United States-based startup that focuses on Healthcare Insights Through Machine Learning. Established in 2014, Atomo leverages machine learning and advanced analytics to identify individuals and populations with the highest unmet medical need for a given disease or condition. With over 30 years of experience in Healthcare, Life Sciences, and Health Economics and Outcomes Research, Atomo's solutions aim to integrate disparate data sets to identify patients and populations with the highest unmet needs. Furthermore, the company aims to discover the optimal ways to address these needs. The company operates in the Health Care and Information Technology industries, positioning itself at the intersection of healthcare and technology. Although specific investment details are not currently available, Atomo's innovative approach to utilizing machine learning and advanced analytics in the healthcare sector presents an attractive proposition for potential investors. As the healthcare industry increasingly embraces data-driven solutions, Atomo's expertise and experience make it a compelling player in addressing unmet medical needs. With a strong track record and a focus on leveraging technology for better healthcare outcomes, Atomo presents an intriguing opportunity for investors looking to be part of the transformative healthcare technology landscape.
There is no investment information
No recent news or press coverage available for Atomo, Inc.